Abstract
Amyloidosis is the result of misfolded protein deposition in organs and tissues, including the heart also known as cardiac amyloidosis. We describe a case of a patient presenting with decompensated heart failure, which highlights the importance of identifying the etiology of the patient’s cardiomyopathy through a thorough history and physical. This led to a diagnosis of cardiac amyloidosis. The patient was subsequently initiated on tafamidis, a medication that is associated with reductions in all-cause mortality and cardiovascular-related hospitalizations, reduced decline in functional capacity, and improved quality of life of the patient.
Recommended Citation
Pang, MD, Zachary; Riley, MD, Joshua M.; and Lev, MD, Yair
(2024)
"Investigating the Etiology of Non-Ischemic Cardiomyopathy; A Case Report of Cardiac Amyloidosis,"
The Medicine Forum: Vol. 25, Article 9.
DOI: https://doi.org/10.29046/TMF.025.1.008
Available at:
https://jdc.jefferson.edu/tmf/vol25/iss1/9
